Replies to post #333552 on Anavex Life Sciences Corp (AVXL)

[WolfofMia]

Not high at all, some drugs with less efficacy are priced way higher for autoimmune disease (not a rare disease).

The list price of STELARA® is $12,332 per month.

Rare diseases carry a higher price tag.

[Fireman02360]

Market has not priced it wrong

Thats your opinion. Mine is that they have, big time.

I heard the same thing with many investments I have made.

All are gambles, aren't they? Nobody made life-changing types of money buying a stock after the risk was removed.

You pretty much confirmed my thinking:

this stock has great potential

With a 1 billion MC, Anavex risk/reward profile is superb. Thanks.

-Fireman